Comparing high LET 227Th- and low LET 177Lu-trastuzumab in mice with HER-2 positive SKBR-3 xenografts.

Current radiopharmaceuticals

Volumn 6, Issue 2, 2013, Pages 78-86

  Abbas, Nasir ^a   Heyerdahl, Helen ^b   Bruland, Øyvind S ^b   Brevik, Ellen Mengshoel ^b   Dahle, Jostein ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY CONJUGATE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; MONOCLONAL ANTIBODY; ORGANOMETALLIC COMPOUND; RADIOPHARMACEUTICAL AGENT; THORIUM-227DOTA-P-BENZYL-TRASTUZUMAB;

ALPHA RADIATION; ANIMAL; BAGG ALBINO MOUSE; BREAST NEOPLASMS; COMPARATIVE STUDY; ELECTRON; FEMALE; LEUKOCYTE COUNT; MAMMARY NEOPLASMS, EXPERIMENTAL; METABOLISM; MOUSE; PROCEDURES; RADIOIMMUNOTHERAPY; THERAPEUTIC USE; TISSUE DISTRIBUTION; TREATMENT OUTCOME;

ALPHA PARTICLES; ANIMALS; ANTIBODIES, MONOCLONAL, HUMANIZED; BETA PARTICLES; BREAST NEOPLASMS; FEMALE; IMMUNOCONJUGATES; LEUKOCYTE COUNT; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; ORGANOMETALLIC COMPOUNDS; RADIOIMMUNOTHERAPY; RADIOPHARMACEUTICALS; RECEPTOR, ERBB-2; TISSUE DISTRIBUTION; TREATMENT OUTCOME;

EID: 84891398251     PISSN: None     EISSN: 18744729     Source Type: Journal    
DOI: None     Document Type: Article

References (0)